pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
ROCHE · news · pharmadog
← back to ROCHE
News mentioning ROCHE
412
stories
19h
As part of sales reorganization, Novo will cut 215 employees at US HQ
biospace
20h
STAT+: Pharmalittle: We’re reading about Sanofi eyeing Insmed, AI speeding drug development, and more
stat
1d
‘It’s a very healthy sector’: Biopharma gathers in London as M&A shines and China clouds loom
fiercebiotech
1d
STAT+: Big drugmakers tell House committee they will halt clinical trials at some hospitals in China
stat
1d
STAT+: Pharmalittle: We’re reading about a Merck AI deal, China and the pharma supply chain, and more
stat
2d
Teva loses R&D head Eric Hughes amid push to grow innovative medicines business
fiercebiotech
2d
STAT+: NIH to move last group of its research chimps to a sanctuary
stat
2d
CTAD 2026: Biogen, AriBio lead the way in slowing cognitive decline in Alzheimer’s
biospace
2d
STAT+: Pharmalittle: We’re reading about Overton FDA nomination being yanked, a Merck setback, and more
stat
2d
FDA publishes rejection letter for Summit drug; Nuvalent buyout pays more dividends for GSK
biopharma dive
3d
5 acquisitions that forced Big Pharmas to co-parent
biospace
3d
At Fierce’s London event, Big Pharmas tell biotechs to ‘be transparent’ to secure deals
fiercebiotech
3d
Roche breast cancer pill cleared by FDA
biopharma dive
3d
STAT+: Flagship opens biotech-creation outpost in the U.K.
stat
3d
U.S. loses measles elimination status, marking embarrassing stain on its public health record
stat
3d
Novo revamps its direct-to-consumer platform; Roche drug Gazyva approved again
endpoints
3d
CTAD 2026: AriBio’s Alzheimer’s candidate slows cognitive decline as monotherapy
biospace
3d
STAT+: Pharmalittle: We’re reading about a Roche breast cancer pill, obesity drugs in children, and more
stat
3d
Roche enters the SERD market with FDA approval in late-stage breast cancer
endpoints
4d
Flavored nicotine tablets, the tobacco industry’s latest product, worry public health advocates
stat
4d
Recon: FDA approves Roche’s oral SERD for late-stage breast cancer; Lilly strikes up to $5.9B cancer deal with Stipple Bio
raps
4d
STAT+: FDA approves new breast cancer drug, providing new option for some patients, boost for Roche
stat
4d
Sellas marks 9-month survival benefit in late-stage leukemia vaccine study
fiercebiotech
4d
J&J bets $2.2B on Ollin’s vision loss drug
biopharma dive
4d
Their loss, our gain? Canada makes its case to Europe amid U.S. instability
biospace
5d
The infrastructure decisions that will enable tomorrow’s biggest breakthroughs
biopharma dive
5d
J&J pays $2.2B upfront for Ollin to challenge Roche’s Vabysmo with phase 3 bispecific
fiercebiotech
5d
Alzheimer’s field looks beyond amyloid as biopharma converges at CTAD 2026
biospace
7d
Biopharma pushes beyond GLP-1s, weight loss at ObesityWeek 2026
biospace
9d
Drug price hikes in Germany could push US costs higher, study says
biopharma dive
← prev
page 1 of 14
next →